BRAFTOVI vs MEKINIST

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. BRAFTOVI and MEKINIST are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BRAFTOVI	MEKINIST
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ENCORAFENIB	TRAMETINIB DIMETHYL SULFOXIDE
Manufacturer	Array Biopharma Inc	Novartis
Dosage forms	Capsule	Powder, Tablet
Drug class	—	Kinase Inhibitor
Boxed warning	None	None
Treats	Melanoma	Non-Small-Cell Lung Carcinoma, Melanoma

braftovi mekinist

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

ENCORAFENIB

TRAMETINIB DIMETHYL SULFOXIDE

Manufacturer

Array Biopharma Inc

Novartis

Dosage forms

Capsule

Powder, Tablet

Drug class

—

Kinase Inhibitor

Boxed warning

None

Treats

Melanoma

Non-Small-Cell Lung Carcinoma, Melanoma

Frequently asked questions

What is the difference between Braftovi and Mekinist?

Braftovi contains Encorafenib, while Mekinist contains Trametinib Dimethyl Sulfoxide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.